KeyBank National Association
MRNA icon

KeyBank National Association’s Moderna MRNA Stock Holding History

KeyBank National Association’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Buy
9,069
+1,852
+26% +$95.8K ﹤0.01% 810
2026
Q1 		$367K Buy
+7,217
New +$337K ﹤0.01% 955
2024
Q4 		– Sell
-3,586
Closed -$240K – 1178
2024
Q3 		$240K Sell
3,586
-342
-9% -$31.4K ﹤0.01% 1047
2024
Q2 		$466K Buy
3,928
+394
+11% +$49.9K ﹤0.01% 769
2024
Q1 		$377K Buy
+3,534
New +$356K ﹤0.01% 868
2023
Q4 		– Sell
-3,176
Closed -$328K – 1096
2023
Q3 		$328K Sell
3,176
-39
-1% -$4.35K ﹤0.01% 848
2023
Q2 		$391K Buy
3,215
+266
+9% +$35.5K ﹤0.01% 791
2023
Q1 		$453K Sell
2,949
-277
-9% -$45.7K ﹤0.01% 741
2022
Q4 		$579K Buy
3,226
+198
+7% +$32.4K ﹤0.01% 638
2022
Q3 		$358K Sell
3,028
-195
-6% -$29.6K ﹤0.01% 777
2022
Q2 		$460K Buy
3,223
+346
+12% +$49.5K ﹤0.01% 700
2022
Q1 		$496K Buy
2,877
+521
+22% +$87.7K ﹤0.01% 733
2021
Q4 		$598K Sell
2,356
-973
-29% -$284K ﹤0.01% 754
2021
Q3 		$1.28M Buy
3,329
+1,139
+52% +$420K 0.01% 483
2021
Q2 		$515K Sell
2,190
-800
-27% -$143K ﹤0.01% 785
2021
Q1 		$392K Buy
2,990
+887
+42% +$129K ﹤0.01% 856
2020
Q4 		$220K Buy
+2,103
New +$213K ﹤0.01% 981

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

KeyBank National Association's MRNA Position: Q2 2026 in Review

KeyBank National Association increased its Moderna (MRNA) stake by 26% in Q2 2026, buying an estimated $95.8K and bringing the position to 9,069 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

KeyBank National Association first reported a position in MRNA in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.28M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • KeyBank National Association held 9,069 shares of Moderna worth $635K as of Q2 2026.
  • KeyBank National Association bought 1,852 Moderna shares in Q2 2026, an estimated $95.8K.
  • Moderna made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #810 holding.
  • KeyBank National Association first reported a position in Moderna in Q4 2020 and has held it in 17 quarters since.
  • KeyBank National Association's Moderna position peaked at $1.28M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.